Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine
about
Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine
description
im Juli 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2010
@uk
name
Nasal associated lymphoid tiss ...... recombinant adenoviral vaccine
@en
Nasal associated lymphoid tissue
@nl
type
label
Nasal associated lymphoid tiss ...... recombinant adenoviral vaccine
@en
Nasal associated lymphoid tissue
@nl
prefLabel
Nasal associated lymphoid tiss ...... recombinant adenoviral vaccine
@en
Nasal associated lymphoid tissue
@nl
P2093
P921
P1433
P1476
Nasal associated lymphoid tiss ...... recombinant adenoviral vaccine
@en
P2093
Edward O. Ronan
Elma Z. Tchilian
Peter C.L. Beverley
P304
P356
10.1016/J.VACCINE.2010.05.075
P407
P50
P577
2010-07-01T00:00:00Z